A retrospective MIMIC-IV analysis of 31,888 sepsis patients reported that documented low-dose aspirin use was associated with lower early mortality, but the authors cautioned that causality is uncertain. The signal was framed as an observational finding requiring prospective validation. Clinicians and trial designers are likely to interpret the result as hypothesis-generating rather than practice-changing, particularly given confounding risks in retrospective cohorts and the need to establish timing, dose, and patient selection effects.